Are Liver Function Tests (LFTs) Included in a Comprehensive Metabolic Panel (CMP)?
No, liver function tests (LFTs) are NOT fully included in a comprehensive metabolic panel (CMP), though there is partial overlap with some components.
What's Actually in Each Panel
Comprehensive Metabolic Panel (CMP) Components
A CMP typically includes 1:
- Glucose
- Electrolytes (sodium, potassium, chloride, bicarbonate)
- Kidney function markers (BUN, creatinine)
- Calcium
- Limited liver-related tests: albumin, total bilirubin, alkaline phosphatase (ALP), ALT, and AST 2
Complete Liver Function Tests (LFTs)
A comprehensive liver blood test panel should include 1:
- Bilirubin (included in CMP)
- Albumin (included in CMP)
- ALT (alanine aminotransferase) - may be in CMP
- ALP (alkaline phosphatase) - may be in CMP
- GGT (gamma-glutamyl transferase) - NOT in CMP
- AST (aspartate aminotransferase) - may be in CMP
- Full blood count (if not done within 12 months) - NOT in CMP
The Critical Gap
The most significant limitation is that GGT is not included in a standard CMP 1. GGT is essential because it increases the sensitivity of detecting liver disease, particularly in patients with non-alcoholic fatty liver disease (NAFLD) and alcohol-related liver disease (ARLD), which account for 90% of liver mortality 1. While adding GGT increases the likelihood of detecting abnormal liver tests from 15% to 30%, it does reduce specificity 1.
Clinical Implications
When CMP is Insufficient
For proper liver disease screening, you need additional tests beyond the CMP 1:
- GGT must be added for adequate sensitivity in detecting fatty liver disease and alcohol-related disease 1
- PT/INR should be checked to assess synthetic liver function (clotting factors II, V, VII, IX, X) 1
- Platelet count is crucial as thrombocytopenia indicates advanced liver disease and portal hypertension 1
The Terminology Problem
The term "liver function tests" is actually a misnomer 1. Most tests measure hepatobiliary enzyme elevation (indicating injury) rather than actual liver function 1. True markers of liver synthetic function are albumin, PT/INR, and bilirubin 1.
Cost-Effectiveness Considerations
Ordering a CMP when you need liver evaluation may be false economy 2. A study showed potential savings of $7,125 annually by using basic metabolic panels (BMP) instead of CMP in patients without clinical indicators of liver disease 2. However, if liver disease is suspected, you'll need to order additional tests anyway, negating any initial savings 3.
Practical Recommendation Algorithm
If screening for liver disease:
- Do NOT rely on CMP alone 1
- Order a dedicated liver panel that includes: bilirubin, albumin, ALT, ALP, GGT, plus full blood count 1
- Add AST if available to calculate AST:ALT ratio (>1 suggests advanced fibrosis/cirrhosis) 1
- Consider PT/INR if synthetic dysfunction suspected 1
If ordering routine metabolic screening without liver disease suspicion:
- CMP is appropriate 4
- Add specific liver tests only if clinical indicators present (right upper quadrant pain, jaundice, hepatomegaly, history of liver/heart disease) 2
Common Pitfalls to Avoid
- Don't assume a normal CMP rules out liver disease - enzymes can be normal even in cirrhosis 1
- Don't order CMP expecting complete liver evaluation - you're missing GGT and proper assessment of synthetic function 1
- Don't ignore the AST:ALT ratio - this can indicate advanced fibrosis even when both values are within normal range 1
- Remember albumin has limited specificity - it decreases in sepsis, inflammatory disorders, nephrotic syndrome, and malabsorption, not just liver disease 1